MMT-2'-O-Methyl adenosine (n-bz) CED phosphoramidite

• UNSPSC Description:

  MMT-2'-O-Methyl adenosine (n-bz) CED phosphoramidite (compound 1) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies[1].

• Target Antigen:

  Nucleoside Antimetabolite/Analog

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/mmt-2-o-methyl-adenosine-n-bz-ced-phosphoramidite.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CO[C@@H]1[C@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@H](O[C@H]1N2C(N=CN=C3NC(C4=CC=CC=C4)=O)=C3N=C2)COC(C5=CC=C(OC)C=C5)(C6=CC=CC=C6)C7=CC=CC=C7

• Molecular Weight:

  857.93

• References & Citations:

  [1]Senthilvelan A, et al. Efficient and Improved Solution-Phase Synthesis of Modified RNA Dinucleotides: Versatile Synthons in Cap 1 mRNA Therapeutics[J]. Organic Process Research & Development, 2022, 26(9): 2771-2778.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2645354-88-5